APO Research
Talk to an analyst

APO RESEARCH · REPORT

Furosemide Injection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Furosemide Injection Industry Growth and Trends Forecast to 2032

2 January 2026100 pages

Choose your research edition.

Industry ResearchFurosemide Injection Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Furosemide Injection Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Furosemide Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Furosemide Injection Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Furosemide Injection Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Furosemide Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Furosemide Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Furosemide Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Furosemide Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Furosemide Injection include AuroMedics, Avet Pharmaceuticals, SteriMax, Baxter, Chengdu Brilliant Pharmaceutical, Fresenius Kabi, Hainan Huanglong Pharm, Hunan Kelun Pharmaceutical and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Furosemide Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Furosemide Injection market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Furosemide Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Furosemide Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Furosemide Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Furosemide Injection Market by Company

AuroMedics

Avet Pharmaceuticals

SteriMax

Baxter

Chengdu Brilliant Pharmaceutical

Fresenius Kabi

Hainan Huanglong Pharm

Hunan Kelun Pharmaceutical

Pfizer

Shagnhai Harvest Pharamceutical

Shenyang Guagnda Pharm

CSPC Ouyi Pharm

Changbaishan Pharmaceutical

Furosemide Injection Segment by Type

40mg/40ml

20mg/2ml

100mg/10ml

Furosemide Injection Segment by Application

Recovery Center

Hospital

Clinics

Furosemide Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Furosemide Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Furosemide Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Furosemide Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Furosemide Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Furosemide Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 40mg/40ml Table 2. Major Company of 20mg/2ml Table 3. Major Company of 100mg/10ml Table 4. Global Furosemide Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Furosemide Injection Sales by Type (2021-2026) & (W Units) Table 6. Global Furosemide Injection Sales Market Share in Volume by Type (2021-2026) Table 7. Global Furosemide Injection Sales by Type (2021-2026) & (US$ Million) Table 8. Global Furosemide Injection Sales Market Share in Value by Type (2021-2026) Table 9. Global Furosemide Injection Price by Type (2021-2026) & (US$/Unit) Table 10. Global Furosemide Injection Sales by Type (2027-2032) & (W Units) Table 11. Global Furosemide Injection Sales Market Share in Volume by Type (2027-2032) Table 12. Global Furosemide Injection Sales by Type (2027-2032) & (US$ Million) Table 13. Global Furosemide Injection Sales Market Share in Value by Type (2027-2032) Table 14. Global Furosemide Injection Price by Type (2027-2032) & (US$/Unit) Table 15. North America Furosemide Injection Sales by Type (2021-2026) & (W Units) Table 16. North America Furosemide Injection Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Furosemide Injection Sales by Type (2021-2026) & (W Units) Table 18. Europe Furosemide Injection Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Furosemide Injection Sales by Type (2021-2026) & (W Units) Table 20. Asia-Pacific Furosemide Injection Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Furosemide Injection Sales by Type (2021-2026) & (W Units) Table 22. Latin America Furosemide Injection Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Furosemide Injection Sales by Type (2021-2026) & (W Units) Table 24. Middle East and Africa Furosemide Injection Sales by Type (2021-2026) & (US$ Million) Table 25. Furosemide Injection Industry Trends Table 26. Furosemide Injection Industry Drivers Table 27. Furosemide Injection Industry Opportunities and Challenges Table 28. Furosemide Injection Industry Restraints Table 29. Global Furosemide Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Furosemide Injection Revenue Market Share by Company (2021-2026) Table 31. Global Furosemide Injection Sales by Company (2021-2026) & (W Units) Table 32. Global Furosemide Injection Sales Share by Company (2021-2026) Table 33. Global Furosemide Injection Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Furosemide Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Furosemide Injection Major Company Production Sites and Headquarters Table 36. Global Furosemide Injection Company, Product Type & Application Table 37. Global Furosemide Injection Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Furosemide Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Furosemide Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Furosemide Injection Sales by Region (2021-2026) & (W Units) Table 42. Global Furosemide Injection Sales Market Share in Volume by Region (2021-2026) Table 43. Global Furosemide Injection Sales by Region (2021-2026) & (US$ Million) Table 44. Global Furosemide Injection Sales Market Share in Value by Region (2021-2026) Table 45. Global Furosemide Injection Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Furosemide Injection Sales by Region (2027-2032) & (W Units) Table 47. Global Furosemide Injection Sales Market Share in Volume by Region (2027-2032) Table 48. Global Furosemide Injection Sales by Region (2027-2032) & (US$ Million) Table 49. Global Furosemide Injection Sales Market Share in Value by Region (2027-2032) Table 50. Global Furosemide Injection Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Furosemide Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Furosemide Injection Sales by Application (2021-2026) & (W Units) Table 53. Global Furosemide Injection Sales Market Share in Volume by Application (2021-2026) Table 54. Global Furosemide Injection Sales by Application (2021-2026) & (US$ Million) Table 55. Global Furosemide Injection Sales Market Share in Value by Application (2021-2026) Table 56. Global Furosemide Injection Price by Application (2021-2026) & (US$/Unit) Table 57. Global Furosemide Injection Sales by Application (2027-2032) & (W Units) Table 58. Global Furosemide Injection Sales Market Share in Volume by Application (2027-2032) Table 59. Global Furosemide Injection Sales by Application (2027-2032) & (US$ Million) Table 60. Global Furosemide Injection Sales Market Share in Value by Application (2027-2032) Table 61. Global Furosemide Injection Price by Application (2027-2032) & (US$/Unit) Table 62. North America Furosemide Injection Sales by Application (2021-2026) & (W Units) Table 63. North America Furosemide Injection Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Furosemide Injection Sales by Application (2021-2026) & (W Units) Table 65. Europe Furosemide Injection Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Furosemide Injection Sales by Application (2021-2026) & (W Units) Table 67. Asia-Pacific Furosemide Injection Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Furosemide Injection Sales by Application (2021-2026) & (W Units) Table 69. Latin America Furosemide Injection Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Furosemide Injection Sales by Application (2021-2026) & (W Units) Table 71. Middle East and Africa Furosemide Injection Sales by Application (2021-2026) & (US$ Million) Table 72. AuroMedics Company Information Table 73. AuroMedics Business Overview Table 74. AuroMedics Furosemide Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. AuroMedics Furosemide Injection Product Portfolio Table 76. AuroMedics Recent Development Table 77. Avet Pharmaceuticals Company Information Table 78. Avet Pharmaceuticals Business Overview Table 79. Avet Pharmaceuticals Furosemide Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Avet Pharmaceuticals Furosemide Injection Product Portfolio Table 81. Avet Pharmaceuticals Recent Development Table 82. SteriMax Company Information Table 83. SteriMax Business Overview Table 84. SteriMax Furosemide Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. SteriMax Furosemide Injection Product Portfolio Table 86. SteriMax Recent Development Table 87. Baxter Company Information Table 88. Baxter Business Overview Table 89. Baxter Furosemide Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Baxter Furosemide Injection Product Portfolio Table 91. Baxter Recent Development Table 92. Chengdu Brilliant Pharmaceutical Company Information Table 93. Chengdu Brilliant Pharmaceutical Business Overview Table 94. Chengdu Brilliant Pharmaceutical Furosemide Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Chengdu Brilliant Pharmaceutical Furosemide Injection Product Portfolio Table 96. Chengdu Brilliant Pharmaceutical Recent Development Table 97. Fresenius Kabi Company Information Table 98. Fresenius Kabi Business Overview Table 99. Fresenius Kabi Furosemide Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Fresenius Kabi Furosemide Injection Product Portfolio Table 101. Fresenius Kabi Recent Development Table 102. Hainan Huanglong Pharm Company Information Table 103. Hainan Huanglong Pharm Business Overview Table 104. Hainan Huanglong Pharm Furosemide Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Hainan Huanglong Pharm Furosemide Injection Product Portfolio Table 106. Hainan Huanglong Pharm Recent Development Table 107. Hunan Kelun Pharmaceutical Company Information Table 108. Hunan Kelun Pharmaceutical Business Overview Table 109. Hunan Kelun Pharmaceutical Furosemide Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Hunan Kelun Pharmaceutical Furosemide Injection Product Portfolio Table 111. Hunan Kelun Pharmaceutical Recent Development Table 112. Pfizer Company Information Table 113. Pfizer Business Overview Table 114. Pfizer Furosemide Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Pfizer Furosemide Injection Product Portfolio Table 116. Pfizer Recent Development Table 117. Shagnhai Harvest Pharamceutical Company Information Table 118. Shagnhai Harvest Pharamceutical Business Overview Table 119. Shagnhai Harvest Pharamceutical Furosemide Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Shagnhai Harvest Pharamceutical Furosemide Injection Product Portfolio Table 121. Shagnhai Harvest Pharamceutical Recent Development Table 122. Shenyang Guagnda Pharm Company Information Table 123. Shenyang Guagnda Pharm Business Overview Table 124. Shenyang Guagnda Pharm Furosemide Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Shenyang Guagnda Pharm Furosemide Injection Product Portfolio Table 126. Shenyang Guagnda Pharm Recent Development Table 127. CSPC Ouyi Pharm Company Information Table 128. CSPC Ouyi Pharm Business Overview Table 129. CSPC Ouyi Pharm Furosemide Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. CSPC Ouyi Pharm Furosemide Injection Product Portfolio Table 131. CSPC Ouyi Pharm Recent Development Table 132. Changbaishan Pharmaceutical Company Information Table 133. Changbaishan Pharmaceutical Business Overview Table 134. Changbaishan Pharmaceutical Furosemide Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Changbaishan Pharmaceutical Furosemide Injection Product Portfolio Table 136. Changbaishan Pharmaceutical Recent Development Table 137. North America Furosemide Injection Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 138. North America Furosemide Injection Sales by Country (2021-2026) & (W Units) Table 139. North America Furosemide Injection Sales Market Share by Country (2021-2026) Table 140. North America Furosemide Injection Sales Forecast by Country (2027-2032) & (W Units) Table 141. North America Furosemide Injection Sales Market Share Forecast by Country (2027-2032) Table 142. North America Furosemide Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. North America Furosemide Injection Market Size by Country (2021-2026) & (US$ Million) Table 144. North America Furosemide Injection Market Share by Country (2021-2026) Table 145. North America Furosemide Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. North America Furosemide Injection Market Share Forecast by Country (2027-2032) Table 147. Europe Furosemide Injection Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 148. Europe Furosemide Injection Sales by Country (2021-2026) & (W Units) Table 149. Europe Furosemide Injection Sales Market Share by Country (2021-2026) Table 150. Europe Furosemide Injection Sales Forecast by Country (2027-2032) & (W Units) Table 151. Europe Furosemide Injection Sales Market Share Forecast by Country (2027-2032) Table 152. Europe Furosemide Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Europe Furosemide Injection Market Size by Country (2021-2026) & (US$ Million) Table 154. Europe Furosemide Injection Market Share by Country (2021-2026) Table 155. Europe Furosemide Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Europe Furosemide Injection Market Share Forecast by Country (2027-2032) Table 157. Asia-Pacific Furosemide Injection Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 158. Asia-Pacific Furosemide Injection Sales by Country (2021-2026) & (W Units) Table 159. Asia-Pacific Furosemide Injection Sales Market Share by Country (2021-2026) Table 160. Asia-Pacific Furosemide Injection Sales Forecast by Country (2027-2032) & (W Units) Table 161. Asia-Pacific Furosemide Injection Sales Market Share Forecast by Country (2027-2032) Table 162. Asia-Pacific Furosemide Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Asia-Pacific Furosemide Injection Market Size by Country (2021-2026) & (US$ Million) Table 164. Asia-Pacific Furosemide Injection Market Share by Country (2021-2026) Table 165. Asia-Pacific Furosemide Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Asia-Pacific Furosemide Injection Market Share Forecast by Country (2027-2032) Table 167. Latin America Furosemide Injection Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 168. Latin America Furosemide Injection Sales by Country (2021-2026) & (W Units) Table 169. Latin America Furosemide Injection Sales Market Share by Country (2021-2026) Table 170. Latin America Furosemide Injection Sales Forecast by Country (2027-2032) & (W Units) Table 171. Latin America Furosemide Injection Sales Market Share Forecast by Country (2027-2032) Table 172. Latin America Furosemide Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Latin America Furosemide Injection Market Size by Country (2021-2026) & (US$ Million) Table 174. Latin America Furosemide Injection Market Share by Country (2021-2026) Table 175. Latin America Furosemide Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Latin America Furosemide Injection Market Share Forecast by Country (2027-2032) Table 177. Middle East and Africa Furosemide Injection Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 178. Middle East and Africa Furosemide Injection Sales by Country (2021-2026) & (W Units) Table 179. Middle East and Africa Furosemide Injection Sales Market Share by Country (2021-2026) Table 180. Middle East and Africa Furosemide Injection Sales Forecast by Country (2027-2032) & (W Units) Table 181. Middle East and Africa Furosemide Injection Sales Market Share Forecast by Country (2027-2032) Table 182. Middle East and Africa Furosemide Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 183. Middle East and Africa Furosemide Injection Market Size by Country (2021-2026) & (US$ Million) Table 184. Middle East and Africa Furosemide Injection Market Share by Country (2021-2026) Table 185. Middle East and Africa Furosemide Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 186. Middle East and Africa Furosemide Injection Market Share Forecast by Country (2027-2032) Table 187. Key Raw Materials Table 188. Raw Materials Key Suppliers Table 189. Furosemide Injection Distributors List Table 190. Furosemide Injection Customers List Table 191. Research Programs/Design for This Report Table 192. Authors List of This Report Table 193. Secondary Sources Table 194. Primary Sources List of Figures Figure 1. Furosemide Injection Image Figure 2. Global Furosemide Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Furosemide Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Furosemide Injection Sales (2021-2032) & (W Units) Figure 5. 40mg/40ml Image Figure 6. Global 40mg/40ml Sales YoY Growth (2021-2032) & (W Units) Figure 7. 20mg/2ml Image Figure 8. Global 20mg/2ml Sales YoY Growth (2021-2032) & (W Units) Figure 9. 100mg/10ml Image Figure 10. Global 100mg/10ml Sales YoY Growth (2021-2032) & (W Units) Figure 11. Global Furosemide Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Furosemide Injection Market Share by Type 2025 VS 2032 Figure 13. North America Furosemide Injection Sales Market Share in Volume by Type in 2025 Figure 14. North America Furosemide Injection Sales Market Share in Value by Type in 2025 Figure 15. Europe Furosemide Injection Sales Market Share in Volume by Type in 2025 Figure 16. Europe Furosemide Injection Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Furosemide Injection Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Furosemide Injection Sales Market Share in Value by Type in 2025 Figure 19. Latin America Furosemide Injection Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Furosemide Injection Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Furosemide Injection Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Furosemide Injection Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Furosemide Injection Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Recovery Center Image Figure 26. Global Recovery Center Sales YoY Growth (2021-2032) & (W Units) Figure 27. Hospital Image Figure 28. Global Hospital Sales YoY Growth (2021-2032) & (W Units) Figure 29. Clinics Image Figure 30. Global Clinics Sales YoY Growth (2021-2032) & (W Units) Figure 31. Global Furosemide Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Furosemide Injection Market Share by Application 2025 VS 2032 Figure 33. North America Furosemide Injection Sales Market Share in Volume by Application in 2025 Figure 34. North America Furosemide Injection Sales Market Share in Value by Application in 2025 Figure 35. Europe Furosemide Injection Sales Market Share in Volume by Application in 2025 Figure 36. Europe Furosemide Injection Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Furosemide Injection Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Furosemide Injection Sales Market Share in Value by Application in 2025 Figure 39. Latin America Furosemide Injection Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Furosemide Injection Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Furosemide Injection Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Furosemide Injection Sales Market Share in Value by Application in 2025 Figure 43. North America Furosemide Injection Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 44. North America Furosemide Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Furosemide Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Furosemide Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Furosemide Injection Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 48. Europe Furosemide Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Furosemide Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Furosemide Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Furosemide Injection Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 52. Asia-Pacific Furosemide Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Furosemide Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Furosemide Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Furosemide Injection Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 56. Latin America Furosemide Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Furosemide Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Furosemide Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Furosemide Injection Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 60. Middle East and Africa Furosemide Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Furosemide Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Furosemide Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Furosemide Injection Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Furosemide Injection Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 40mg/40ml
  • 20mg/2ml
  • 100mg/10ml
Applications
  • Recovery Center
  • Hospital
  • Clinics
Companies covered
  • AuroMedics
  • Avet Pharmaceuticals
  • SteriMax
  • Baxter
  • Chengdu Brilliant Pharmaceutical
  • Fresenius Kabi
  • Hainan Huanglong Pharm
  • Hunan Kelun Pharmaceutical
  • Pfizer
  • Shagnhai Harvest Pharamceutical
  • Shenyang Guagnda Pharm
  • CSPC Ouyi Pharm
  • Changbaishan Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Furosemide Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Furosemide Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Furosemide Injection Market by Type
  6. 1.3.1 40mg/40ml
  7. 1.3.2 20mg/2ml
  8. 1.3.3 100mg/10ml
  9. 1.4 Global Furosemide Injection Market Size by Type
  10. 1.4.1 Global Furosemide Injection Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Furosemide Injection Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Furosemide Injection Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Furosemide Injection Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Furosemide Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Furosemide Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Furosemide Injection Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Furosemide Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Furosemide Injection Industry Trends
  2. 2.2 Furosemide Injection Industry Drivers
  3. 2.3 Furosemide Injection Industry Opportunities and Challenges
  4. 2.4 Furosemide Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Furosemide Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Furosemide Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Furosemide Injection Price (2021-2026)
  4. 3.4 Global Furosemide Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Furosemide Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Furosemide Injection Company, Product Type & Application
  7. 3.7 Global Furosemide Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Furosemide Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Furosemide Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Furosemide Injection Tier 1, Tier 2, and Tier 3
4 Furosemide Injection Regional Status and Outlook
  1. 4.1 Global Furosemide Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Furosemide Injection Historic Market Size by Region
  3. 4.2.1 Global Furosemide Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Furosemide Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Furosemide Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Furosemide Injection Forecasted Market Size by Region
  7. 4.3.1 Global Furosemide Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Furosemide Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Furosemide Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Furosemide Injection by Application
  1. 5.1 Furosemide Injection Market by Application
  2. 5.1.1 Recovery Center
  3. 5.1.2 Hospital
  4. 5.1.3 Clinics
  5. 5.2 Global Furosemide Injection Market Size by Application
  6. 5.2.1 Global Furosemide Injection Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Furosemide Injection Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Furosemide Injection Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Furosemide Injection Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Furosemide Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Furosemide Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Furosemide Injection Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Furosemide Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 AuroMedics
  2. 6.1.1 AuroMedics Company Information
  3. 6.1.2 AuroMedics Business Overview
  4. 6.1.3 AuroMedics Furosemide Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 AuroMedics Furosemide Injection Product Portfolio
  6. 6.1.5 AuroMedics Recent Developments
  7. 6.2 Avet Pharmaceuticals
  8. 6.2.1 Avet Pharmaceuticals Company Information
  9. 6.2.2 Avet Pharmaceuticals Business Overview
  10. 6.2.3 Avet Pharmaceuticals Furosemide Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Avet Pharmaceuticals Furosemide Injection Product Portfolio
  12. 6.2.5 Avet Pharmaceuticals Recent Developments
  13. 6.3 SteriMax
  14. 6.3.1 SteriMax Company Information
  15. 6.3.2 SteriMax Business Overview
  16. 6.3.3 SteriMax Furosemide Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 SteriMax Furosemide Injection Product Portfolio
  18. 6.3.5 SteriMax Recent Developments
  19. 6.4 Baxter
  20. 6.4.1 Baxter Company Information
  21. 6.4.2 Baxter Business Overview
  22. 6.4.3 Baxter Furosemide Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Baxter Furosemide Injection Product Portfolio
  24. 6.4.5 Baxter Recent Developments
  25. 6.5 Chengdu Brilliant Pharmaceutical
  26. 6.5.1 Chengdu Brilliant Pharmaceutical Company Information
  27. 6.5.2 Chengdu Brilliant Pharmaceutical Business Overview
  28. 6.5.3 Chengdu Brilliant Pharmaceutical Furosemide Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Chengdu Brilliant Pharmaceutical Furosemide Injection Product Portfolio
  30. 6.5.5 Chengdu Brilliant Pharmaceutical Recent Developments
  31. 6.6 Fresenius Kabi
  32. 6.6.1 Fresenius Kabi Company Information
  33. 6.6.2 Fresenius Kabi Business Overview
  34. 6.6.3 Fresenius Kabi Furosemide Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Fresenius Kabi Furosemide Injection Product Portfolio
  36. 6.6.5 Fresenius Kabi Recent Developments
  37. 6.7 Hainan Huanglong Pharm
  38. 6.7.1 Hainan Huanglong Pharm Company Information
  39. 6.7.2 Hainan Huanglong Pharm Business Overview
  40. 6.7.3 Hainan Huanglong Pharm Furosemide Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Hainan Huanglong Pharm Furosemide Injection Product Portfolio
  42. 6.7.5 Hainan Huanglong Pharm Recent Developments
  43. 6.8 Hunan Kelun Pharmaceutical
  44. 6.8.1 Hunan Kelun Pharmaceutical Company Information
  45. 6.8.2 Hunan Kelun Pharmaceutical Business Overview
  46. 6.8.3 Hunan Kelun Pharmaceutical Furosemide Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Hunan Kelun Pharmaceutical Furosemide Injection Product Portfolio
  48. 6.8.5 Hunan Kelun Pharmaceutical Recent Developments
  49. 6.9 Pfizer
  50. 6.9.1 Pfizer Company Information
  51. 6.9.2 Pfizer Business Overview
  52. 6.9.3 Pfizer Furosemide Injection Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Pfizer Furosemide Injection Product Portfolio
  54. 6.9.5 Pfizer Recent Developments
  55. 6.10 Shagnhai Harvest Pharamceutical
  56. 6.10.1 Shagnhai Harvest Pharamceutical Company Information
  57. 6.10.2 Shagnhai Harvest Pharamceutical Business Overview
  58. 6.10.3 Shagnhai Harvest Pharamceutical Furosemide Injection Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Shagnhai Harvest Pharamceutical Furosemide Injection Product Portfolio
  60. 6.10.5 Shagnhai Harvest Pharamceutical Recent Developments
  61. 6.11 Shenyang Guagnda Pharm
  62. 6.11.1 Shenyang Guagnda Pharm Company Information
  63. 6.11.2 Shenyang Guagnda Pharm Business Overview
  64. 6.11.3 Shenyang Guagnda Pharm Furosemide Injection Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Shenyang Guagnda Pharm Furosemide Injection Product Portfolio
  66. 6.11.5 Shenyang Guagnda Pharm Recent Developments
  67. 6.12 CSPC Ouyi Pharm
  68. 6.12.1 CSPC Ouyi Pharm Company Information
  69. 6.12.2 CSPC Ouyi Pharm Business Overview
  70. 6.12.3 CSPC Ouyi Pharm Furosemide Injection Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 CSPC Ouyi Pharm Furosemide Injection Product Portfolio
  72. 6.12.5 CSPC Ouyi Pharm Recent Developments
  73. 6.13 Changbaishan Pharmaceutical
  74. 6.13.1 Changbaishan Pharmaceutical Company Information
  75. 6.13.2 Changbaishan Pharmaceutical Business Overview
  76. 6.13.3 Changbaishan Pharmaceutical Furosemide Injection Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Changbaishan Pharmaceutical Furosemide Injection Product Portfolio
  78. 6.13.5 Changbaishan Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Furosemide Injection Sales by Country
  2. 7.1.1 North America Furosemide Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Furosemide Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Furosemide Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Furosemide Injection Market Size by Country
  6. 7.2.1 North America Furosemide Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Furosemide Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Furosemide Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Furosemide Injection Sales by Country
  2. 8.1.1 Europe Furosemide Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Furosemide Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Furosemide Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Furosemide Injection Market Size by Country
  6. 8.2.1 Europe Furosemide Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Furosemide Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Furosemide Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Furosemide Injection Sales by Country
  2. 9.1.1 Asia-Pacific Furosemide Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Furosemide Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Furosemide Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Furosemide Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Furosemide Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Furosemide Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Furosemide Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Furosemide Injection Sales by Country
  2. 10.1.1 South America Furosemide Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Furosemide Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Furosemide Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Furosemide Injection Market Size by Country
  6. 10.2.1 South America Furosemide Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Furosemide Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Furosemide Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Furosemide Injection Sales by Country
  2. 11.1.1 Middle East and Africa Furosemide Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Furosemide Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Furosemide Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Furosemide Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Furosemide Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Furosemide Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Furosemide Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Furosemide Injection Value Chain Analysis
  2. 12.1.1 Furosemide Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Furosemide Injection Production Mode & Process
  7. 12.2 Furosemide Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Furosemide Injection Distributors
  10. 12.2.3 Furosemide Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst